Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis C virus nonstructural protein 5B (NS5B) is an RNA-dependent RNA polymerase (RdRp) that plays a central role in the replication of the hepatitis C virus (HCV) genome. It catalyzes the synthesis of new viral RNA strands using the positive-sense viral RNA as a template, making it essential for both translation and production of progeny genomes. NS5B is approximately 66 kDa in size and consists of about 590 amino acids, located at the C-terminus of HCV’s polyprotein. The three-dimensional structure resembles a right hand with three main domains: Palm domain, Finger domain, and Thumb domain. Because NS5B is essential for HCV genome replication—and because no human homolog exists—it represents an ideal target both scientifically and therapeutically. Its inhibition leads directly to cessation of viral propagation within infected hepatocytes.
Inhibition of viral RNA replication by mimicking natural substrates or binding allosterically at sites such as thumb I/II or palm regions, stabilizing inactive conformations or blocking nucleotide incorporation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C Virus Nonstructural Protein 5B Polymerase (NS5B).